Back to Trades
Poulton Jeffrey V.
DirectorCIK 0001782962
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 52
- Companies
- 2
- Active
- 2025–2026
Poulton Jeffrey V., Director, has filed 7 SEC reports (2025–2026), spread across 2 companies, totaling $8.6M in disclosed volume. Weighing $0 bought versus $5.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 10 | CRVO CervoMed Inc. | Poulton Jeffrey V. | Director | Award | $23.7K |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $722.8K |
| Mar 2 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Exercise | $0 |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $695.2K |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $1.0M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $1.7M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $1.0M |
7 filings